Human Health Holdings Ltd
HKEX:1419
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 5-Year Average (0.5), the stock would be worth HK$-0.43 (153% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -1 | HK$0.81 |
0%
|
| 5-Year Average | 0.5 | HK$-0.43 |
-153%
|
| Industry Average | 9.6 | HK$-7.83 |
-1 066%
|
| Country Average | 9.6 | HK$-7.82 |
-1 066%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| HK |
|
Human Health Holdings Ltd
HKEX:1419
|
307.4m HKD | -1 | 11.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.1B USD | 14.2 | 56 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.7B EUR | 7.9 | 13.5 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.6B USD | 0 | 12.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 9.1 | 23.6 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.7B EUR | 9.2 | 17.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 11.7 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 11.9 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 5.3 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | -30.5 | -27.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 7.2 | 13.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 4.8 |
| Median | 9.6 |
| 70th Percentile | 14.9 |
| Max | 9 749.3 |
Other Multiples
Human Health Holdings Ltd
Glance View
Human Health Holdings Ltd. engages in the provision of integrated healthcare services. The company employs 446 full-time employees The company went IPO on 2016-04-01. The firm's general practice services include a broad range of family medicine related healthcare services such as general consultation, diagnostic and preventative healthcare services, treatments, minor procedures, pharmaceutical drug dispensing, vaccinations, physical check-ups, health education activities, provision of occupational health advices and work injury assessment. Its specialties services include general surgery, orthopaedics & traumatology, ophthalmology, otorhinolaryngology, paediatrics surgery, obstetrics & gynaecology, cardiology, gastroenterology & hepatology, respiratory medicine and dermatology. Its dental services comprise general dentistry, specialties dentistry and cosmetic dentistry.
